270 results on '"Schampaert, Erick"'
Search Results
2. Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks
3. Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial
4. Racial Disparities in Acute Coronary Syndrome Management Within a Universal Healthcare Context: Insights From the AMI-OPTIMA Trial
5. Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial
6. Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing
7. Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back Data
8. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion
9. Inaccuracy of brachial blood pressure and its potential impact on treatment and aortic blood pressure estimation
10. Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy
11. Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys
12. Brain Natriuretic Peptide Levels and the Occurrence of Subclinical Pulmonary Edema in Healthy Lowlanders at High Altitude
13. Excellent Outcomes for Transcatheter Aortic Valve Replacement Within 1 Year of Opening a Low-Volume Centre and Consideration of Requirements
14. Echocardiographic Assessment of Cardiac Performance in Response to High Altitude and Development of Subclinical Pulmonary Edema in Healthy Climbers
15. Canada Acute Coronary Syndrome Risk Score: A new risk score for early prognostication in acute coronary syndromes
16. Genetic determinants of response to aspirin: Appraisal of 4 candidate genes
17. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of observational studies
18. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease
19. Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry
20. Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin
21. Impact of Moderate Renal Insufficiency on Restenosis and Adverse Clinical Events After Sirolimus-Eluting and Bare Metal Stent Implantation (from the SIRIUS Trials)
22. Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel
23. Evaluation of the platelet count drop method for assessment of platelet function in comparison with “gold standard” light transmission aggregometry
24. Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
25. Racial disparities in acute coronary syndrome management within a universal healthcare context: Insights from the AMI-OPTIMA trial
26. RACIAL DISPARITIES IN ACUTE CORONARY SYNDROME MANAGEMENT WITHIN THE CANADIAN UNIVERSAL HEALTHCARE SYSTEM: INSIGHTS FROM THE AMI-OPTIMA TRIAL
27. Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada: An Analysis from the C-SIRIUS Trial
28. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
29. The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents
30. Progressive epicardial coronary blood flow reduction fails to produce ST-segment depression at normal heart rates
31. CUFF-BASED AND INTRAARTERIAL BRACHIAL BLOOD PRESSURE MISMATCH AND ITS POTENTIAL IMPACT ON ANTIHYPERTENSIVE TREATMENT AND ESTIMATION OF AORTIC BLOOD PRESSURE
32. Porcine model of intracoronary pulverization of stent struts by rotablation atherectomy
33. TCT CONNECT-299 Long-Term Clinical Outcomes After Revascularization With PCI and CABG for Left Main Disease in Elderly Versus Young Patients: The EXCEL trial
34. Week-Long High-Maintenance Dose Clopidogrel Regimen Achieves Better Platelet Aggregation Inhibition than a Standard Loading Dose before Percutaneous Coronary Intervention: Results of a Double-Blind, Randomized Clinical Trial
35. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients
36. Assessment of VerifyNow P2Y12 Assay Accuracy in Evaluating Clopidogrel-Induced Platelet Inhibition
37. Impact of Platelet Glycoprotein Iib/Iiia Receptor Inhibitors on Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Interventions Using Sirolimus-Eluting Stents
38. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
39. Drug-eluting stents
40. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study
41. Cause of death with bare metal and sirolimus-eluting stents†
42. Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction:Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial
43. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
44. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
45. Immediate Versus Delayed Stenting in Patients with Acute ST-Elevation Myocardial Infarction: A Randomized Open-Label Bayesian Trial
46. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
47. TCT-306 Association Between Prediabetes and Clinical Outcomes After Left Main Coronary Artery Revascularization by PCI or CABG: Analysis From the EXCEL Trial
48. TCT-576 Clinical Outcome of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Practical Routine Clinical Procedures (PRESSUREwire Registry)
49. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes
50. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.